Enhanced efficacy of triprolidine by transdermal application of the EVA matrix system in rabbits and rats

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 61, Issue 1-2, 2005, Pages 14-19

  Shin, Sang Chul ^a   Choi, Jun Shik ^b  

^a Chonnam National University   (South Korea)

^b Chosun University   (South Korea)

Author keywords

Antihistamine effects; Bioavailability; Enhancer; EVA matrix; Transdermal administration; Triprolidine

Indexed keywords

CITRIC ACID TRIETHYL ESTER; ETHYLENE VINYL ACETATE COPOLYMER; EVANS BLUE; PENETRATION ENHANCING AGENT; PLASTICIZER; POLYOXYETHYLENE OLEYL ETHER; TRIPROLIDINE;

ABDOMEN; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL PERMEABILITY; CALCULATION; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG PENETRATION; EXTRACELLULAR MATRIX; FEMORAL ARTERY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; RABBIT; RAT; SKIN ABSORPTION; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CAPILLARY PERMEABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; EVANS BLUE; HISTAMINE H1 ANTAGONISTS; INJECTIONS, INTRAVENOUS; MALE; POLYVINYLS; RABBITS; RATS; TRIPROLIDINE;

EID: 23344453463     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2005.03.010     Document Type: Article

References (13)

1. L. Juhlin, J.R. Gibson, S. Harvey, and L.W. Huson Acrivastine versus clemastine in the treatment of chronic idiopathic urticaria. A double-blind, placebo-controlled study Int. J. Dermatol. 12 1987 653 654
2. J.T. Connell, B.O. Williams, S. Allen, A. Cato, and J.G. Perkins A double-blind controlled evaluation of actipid and its individual constituents in allergic rhinitis J. Int. Med. Res. 10 1982 341
3. L. Diamond, K. Gerson, A. Cato, K. Peace, and J.G. Perkins An evaluation of triprolidine and pseudoephedrine in the treatment of allergic rhinitis Ann. Allergy. 47 1981 87
4. A.R. Gennaro, and Remington The Science and Practice of Pharmacy 19th Ed. 1995 Mack Publishing Company Easton 1207 1218
5. S.C. Shin, and H.J. Lee Controlled release of triprolidine using ethylene-vinyl acetate membrane and matrix system Eur. J. Pharm. Biopharm. 54 2002 201 206
6. S.C. Shin, and H.J. Lee Enhanced controlled delivery of triprolidine from the ethylene-vinyl acetate matrix Eur. J. Pharm. Biopharm. 54 2002 325 328
7. S.T. Holgate The mast cell and its function in allergic disease Clin. Exp. Allergy. 21 1991 11 16
8. R.L. Stevens, and J.F. Austen Recent advances in the cellular and molecular biology of mast cells Immunol. Today 10 1989 381 386
9. S.C. Shin, and M.K. Yoon Application of TPX polymer membranes for the controlled release of triprolidine Int. J. Pharm. 232 2002 131 137
10. 1-receptor antagonist triprolidine: pharmacokinetics and antihistaminic effects J. Allergy Clin. Immunol. 77 1986 326 330
11. M.L. Rocci, and W.J. Jusko LAGRAN program for area and moments in pharmacokinetic analysis Comput. Prog. Biomed. 16 1983 203 216
12. N. Inagaki, T. Miura, H. Nagai, Y. Ono, and A. Koda Inhibition of vascular permeability increase in mice - an addition anti-allergic mechanism of glucocorticoids Int. Arch. Allergy Appl. Immunol. 87 1988 254 259
13. S. Katayama, H. Shionoya, and S. Ohtake A new method for extraction of extravagated dye in the skin and the influence of fasting stress on passive cutaneous anaphylaxis in guinea pigs and rats Microbiol. Immunol. 22 1978 89 101